Social Adjustment and Quality of Life After Very Preterm Birth
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01163188 |
Recruitment Status :
Completed
First Posted : July 15, 2010
Last Update Posted : August 11, 2014
|
Tracking Information | |||||||
---|---|---|---|---|---|---|---|
First Submitted Date | July 14, 2010 | ||||||
First Posted Date | July 15, 2010 | ||||||
Last Update Posted Date | August 11, 2014 | ||||||
Study Start Date | September 2010 | ||||||
Actual Primary Completion Date | January 2014 (Final data collection date for primary outcome measure) | ||||||
Current Primary Outcome Measures |
Quality of life [ Time Frame: 3 years ] Psychologic Interview, face-to-face in Adulthood on one day:
Life Course Interview Wechsler Adult Intelligence Scale Diagnostic Expertsystem Interview for psychotic Symptoms Broad Autism Phenotype Questionaire DANVA Questionaire for ADHD Symptoms TRCB Health Utility Index London Handicap Scale WHO-Quality of Life Satisfaction with Life Scale ANT-I Task Additional Lenght, Weight, Head-, Waist-, Hipfcircumferende were measured. These examinations will be matched with these of previous examinations.
At the second examinationday the selected probands who are physically and mentally able to undergo a functional MRI, will be examined with:
structure-examination DTI Resting Brain ANT N-back These examination will be compared with literature data.
|
||||||
Original Primary Outcome Measures | Not Provided | ||||||
Change History | |||||||
Current Secondary Outcome Measures |
Quality of life [ Time Frame: 3 years ] At the psychological interview the testinstrumentes can be enlarged if possible:
Rapid Automatized Naming Test Color -Word Interferencetest Regensburger verbal fluency test Visual Search and Attention Test Smily task Beck Depression Inventar Achenbach Young Adult Self Report Pittsburgh Sleep Quality index Warwick Edinburgh Mental Wellbeing Scale questionaire for generally health Rosenberg Skala self-esteem mass Arnett Inventory of Sensation Seeking Big Five Inventory-10
|
||||||
Original Secondary Outcome Measures | Not Provided | ||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||
Descriptive Information | |||||||
Brief Title | Social Adjustment and Quality of Life After Very Preterm Birth | ||||||
Official Title | Social Adjustment and Quality of Life After Very Preterm Birth: Risk and Resiliency From Infancy to Adulthood | ||||||
Brief Summary | The major aim is the follow-up of the highest risk group (< 32 weeks gestation/ < 1500 birthweight) and their controls of the Bavarian Longitudinal Study (BLS) at the age of 24-27 years. The focus will be the identification of risk, protective and resiliency factors for cognitive and behavioural development and quality of life. MRIs of the central nervous system will be conducted to examine aberrant activation patterns during the "attention network task" in stratified subgroups. Data driven MRI methods will be evaluated in relation to clinical, behavioural and developmental parameters. |
||||||
Detailed Description | The major aim is the follow-up of the highest risk group (< 32 weeks gestation/ < 1500 birthweight) and their controls of the Bavarian Longitudinal Study (BLS) at the age of 24-27 years. All probands have been assessed previously, neonatally and at additional six time points, the last time at the age of 12-13 years. The focus will be the identification of risk, protective and resiliency factors for cognitive and behavioural development and quality of life. On the basis of previously assessed data statistical modelling of child development until age 8.5 years will be conducted across the total range of gestation from 26-42 weeks to identify social factors amenable to intervention which could be associated with a positive development especially in moderate prematurity. In addition, cross-validation of the findings is planned by means of comparisons with three international studies (Millenium Cohort, GB; POPS, NL; EPICure, GB). MRIs of the central nervous system will be conducted to examine aberrant activation patterns during the "attention network task" in stratified subgroups. Data driven MRI methods will be evaluated in relation to clinical, behavioural and developmental parameters. In line with the objectives of funding there will be a further follow-up of the BLS to answer important questions regarding health and development of very small preterms. | ||||||
Study Type | Observational | ||||||
Study Design | Observational Model: Cohort Time Perspective: Retrospective |
||||||
Target Follow-Up Duration | Not Provided | ||||||
Biospecimen | Retention: Samples Without DNA Description: hair
|
||||||
Sampling Method | Probability Sample | ||||||
Study Population | Very low birthweight (< 1500g birthweight) and/ or very preterm children (< 32 weeks of gestation) and a control group of term born children from the Bavarian Longitudinal Study | ||||||
Condition |
|
||||||
Intervention | Not Provided | ||||||
Study Groups/Cohorts |
|
||||||
Publications * |
|
||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||
Recruitment Information | |||||||
Recruitment Status | Completed | ||||||
Actual Enrollment |
520 | ||||||
Original Estimated Enrollment |
600 | ||||||
Actual Study Completion Date | January 2014 | ||||||
Actual Primary Completion Date | January 2014 (Final data collection date for primary outcome measure) | ||||||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
|
||||||
Sex/Gender |
|
||||||
Ages | 24 Years to 28 Years (Adult) | ||||||
Accepts Healthy Volunteers | No | ||||||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||||||
Listed Location Countries | Germany | ||||||
Removed Location Countries | |||||||
Administrative Information | |||||||
NCT Number | NCT01163188 | ||||||
Other Study ID Numbers | 01ER0801 | ||||||
Has Data Monitoring Committee | Yes | ||||||
U.S. FDA-regulated Product | Not Provided | ||||||
IPD Sharing Statement | Not Provided | ||||||
Current Responsible Party | Peter Bartmann, University Hospital, Bonn | ||||||
Original Responsible Party | Prof. Dr. Dr. Peter Bartmann, University of Bonn, Neonatology | ||||||
Current Study Sponsor | University Hospital, Bonn | ||||||
Original Study Sponsor | Same as current | ||||||
Collaborators |
|
||||||
Investigators |
|
||||||
PRS Account | University Hospital, Bonn | ||||||
Verification Date | August 2014 |